Neuropathy and Related Findings in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To describe the development and progression of neuropathy and related findings among patients with type 1 diabetes who participated in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study. RESEARCH DESIGN AND METHODS: The main diabetic peripheral neuropathy (DPN) outcome was assessed using clinical symptoms, signs, and nerve conduction study results during DCCT and repeated in EDIC year 13/14. Cardiovascular autonomic neuropathy (CAN) was assessed by R-R response to paced breathing, Valsalva ratio, and blood pressure response to standing during DCCT and in EDIC years 13/14 and 16/17. Additionally, symptoms reflecting neuropathic pain and autonomic function (including hypoglycemia awareness) were collected yearly in EDIC using standardized questionnaires; peripheral neuropathy was also assessed annually using the Michigan Neuropathy Screening Instrument. Assessments of genitourinary function were collected at EDIC year 10. RESULTS: Intensive therapy during the DCCT significantly reduced the risk of DPN and CAN at DCCT closeout (64% and 45%, respectively, P < 0.01). The prevalence and incidence of DPN and CAN remained significantly lower in the DCCT intensive therapy group compared with the DCCT conventional therapy group through EDIC year 13/14. CONCLUSIONS: The persistent effects of prior intensive therapy on neuropathy measures through 14 years of EDIC largely mirror those observed for other diabetes complications. DCCT/EDIC provides important information on the influence of glycemic control, and the clinical course of diabetic neuropathy, and, most important, on how to prevent neuropathy in type 1 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A combination of typical symptomatology and symmetrical distal sensory loss, or typical signs in the absence of symptoms, in a person with DM is highly suggestive of DPN and may not require additional evaluations or referral.547,565–567”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [565]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The diagnosis of DPN is principally a clinical one.”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [565]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The Diabetes Control and Complications Trial (DCCT) and its observational follow-up study, Epidemiology of Diabetes Interventions and Complications (EDIC), conclusively demonstrated that intensive glucose control applied early in the course of type 1 diabetes (T1D), significantly reduces the risk of developing CAN [2–4].”
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Electrophysiological testing or referral to a neurologist is rarely needed for diagnosis, except in situations where the clinical features are atypical, the diagnosis is unclear, and a different etiology is suspected.547,554,565”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [565]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Tesfaye, S., Boulton, A. J. M., Dyck, P. J., Freeman, R., Horowitz, M., Kempler, P., Lauria, G., Malik, R. A., Spallone, V., Vinik, A., et al. (2010) · Diabetes Care · doi:10.2337/dc10-1303 · Cited by 2,690
The global burden of diabetic foot disease
Boulton, A. J., Vileikyte, L., Ragnarson-Tennvall, G., & Apelqvist, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67698-2 · Cited by 2,566 · cited 1×
“Painful symptoms are frequently refractory to treatment, and loss of protective sensation heightens the risk for foot ulceration and lowerextremity amputations (19,20).”
BackgroundVascular risk factors and diabetic neuropathy
Tesfaye, S., Chaturvedi, N., Eaton, S. E. M., Ward, J. D., Manes, C., Ionescu-Tirgoviste, C., Witte, D. R., & Fuller, J. H. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa032782 · Cited by 1,323
Feldman, E. L., Stevens, M. J., Thomas, P. K., Brown, M. B., Canal, N., & Greene, D. A. (1994) · Diabetes Care · doi:10.2337/diacare.17.11.1281 · Cited by 1,293
Spallone, V., Ziegler, D., Freeman, R., Bernardi, L., Frontoni, S., Pop‐Busui, R., Stevens, M., Kempler, P., Hilsted, J., Tesfaye, S., et al. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1239 · Cited by 957
Self-citationEffect of intensive therapy on the microvascular complications of type 1 diabetes mellitus
The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.287.19.2563 · Cited by 941
Maser, R. E., Mitchell, B. D., Vinik, A. I., & Freeman, R. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1895 · Cited by 578 · cited 1×
“Yet, CAN is an independent predictor of mortality (21,22), possibly by promoting life-threatening arrhythmias and sudden death in response to a variety of insults including drug side effects, hypoglycemia, hypokalemia, hypotension, or ischemia (23).”
Background
Cited by
Items 501–572 of 572
Baldimtsi, E. (2024) · Linköping University medical dissertations · doi:10.3384/9789180756662
Cardiac Autonomic Neuropathy in Diabetes: A Predictor of Cardiometabolic Events: Overview
Singh, P., Karoli, R., & Shakya, S. (2022) · International Journal of Science and Research (IJSR) · doi:10.21275/sr22101162642
Srisakthi, J., Annadurai, D., & Ganesh Kumar, P. (2025) · International Surgery Journal · doi:10.18203/2349-2902.isj20250140
Rouland, A. (2024) · theses.fr (ABES) · doi:10.70675/6af70b1eze632z469ez88c8zdb045a5e78c6
Singarayar, E. K., Josephrajan, T. A., & Jayabalan, P. (2025) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20250984
Masuda, T., Katakami, N., Taya, N., Miyashita, K., Takahara, M., Kato, K., & Shimomura, I. (2025) · Journal of Diabetes Investigation · doi:10.1111/jdi.70108
“The heightened risks of multiple complications in Group 3, characterized by high HbA 1c levels, align with numerous studies demonstrating hyperglycemia as a signi fi cant risk factor for various diabetic complications 29,33 – 36 .”
S, F. A. S. K., & Lokesh, N. K. (2025) · PARIPEX-INDIAN JOURNAL OF RESEARCH · doi:10.36106/paripex/2501052
Genetikai tényezők szerepe a diabéteszes neuropátia kialakulásában
Hajdú, N., Tordai, D. Z., Rácz, R., Ludvig, Z., Vági, O. E., Békeffy, M. Z., Körei, A. E., Istenes, I., Kempler, P., & Putz, Z. (2025) · Diabetologia Hungarica · doi:10.24121/dh.2025.17
Achchar, A., Aboudrar, S., Benjelloun, H., El-Mhadi, S., Jniene, A., Dakka, T., & Bakkali, M. E. (2025) · Clinical Diabetology · doi:10.5603/cd.105767
Khadilkar, S. V., Mahajan, J., Halani, H., & Rosales, R. L. (2025) · Journal of the Association of Physicians of India · doi:10.59556/japi.73.1118
Fridolfsson, C., Blomstrand, P., Engvall, J. E., & Thegerström, J. (2025) · Annals of Noninvasive Electrocardiology · doi:10.1111/anec.70125
Darol, E. S., & Alemdar, M. (2025) · Journal of Back and Musculoskeletal Rehabilitation · doi:10.1177/10538127251400608
Diabetespatienten mit chronischer Niereninsuffizienz: Neue Aspekte in Diagnostik und Therapie
Pommer, W., & Oser, B. (2014) · Der Diabetologe · doi:10.1007/s11428-014-1274-9
Utsho, A. H. (2024) · heiDOK (Heidelberg University) · doi:10.11588/heidok.00033975
Peripheral Neuropathy in Type 2 Diabetes Mellitus: Strategies for Early Detection
Kumar, M., Nigam, H., & Pandey, A. K. (2023) · International Journal of Pharmaceutical and Clinical Research · doi:10.5281/zenodo.11312443
Khimaniya, P. V., Manseta, N. J., Kishorbhai, C. K., & Chauhan, T. N. (2024) · International Journal of Pharmaceutical and Clinical Research · doi:10.5281/zenodo.14600354
Особенности клинического течения диабетической полинейропатии у пациентов с сахарным диабетом 1 типа
Ходжаева, Д. Т., & Гафарова, С. С. (2024) · Science and Technology in the Modern World · doi:10.70413/zdift-v03-i05-s21379
Non-Invasive Diagnosis of The Cardiac Autonomic Neuropathy In Patients With Diabetes Mellitus
Shuper, V. A., Shuper, S. V., Rykova, J. O., Trefanenko, I. V., Shumko, G. І., & Reva, T. V. (2020) · DSpace BSMU · doi:10.15515/abr.0976-4585.11.4.7579
Shi, L., Wei, H., Zhang, T., Li, Z., Chi, X., Liu, D., Chang, D., Zhang, Y., Wang, X., & Zhao, Q. (2021) · Figshare · doi:10.6084/m9.figshare.16551037
Nabrdalik, K., Irlik, K., Meng, Y., Kwiendacz, H., Piaśnik, J., Hendel, M., Ignacy, P., Kulpa, J., Kegler, K., Herba, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26533785
Lima, L. R. D. (2018) · Americanae (AECID Library)
Nascimento, R. C. G. (2023) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Carvalho, M. M. L. V. D. (2018) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Centenaro, A. (2021) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Investigation of Diabetes-Induced Histological Changes in the Peripheral Sensory Neurons
FILFILAN, R. (2024) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Ciudad Fernandez, L. M., & Ciudad Fernandez, L. M. (2021) · ALICIA National Digital Repository (Antenor Orrego Private University)
FINI, L. (2019) · Electronic Theses and Dissertations Repository (University of Pisa)
Updates in Management of Diabetic Peripheral Neuropathy
Day, A. J. (2023) · eScholarship (California Digital Library)
Efficacy of a plate model on glycaemic control among individuals with type 2 diabetes mellitus
Tiew, K. F. (2015) · Universiti Putra Malaysia Institutional Repository (Universiti Putra Malaysia)
Aghanoori, M. (2019) · Mspace (University of Manitoba)
Cipriani, G. D. F. (2020) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Kalaiarasi, M. K., Angeline, D. A. K., Kavitha, D., & Muthukumaran, M. K. (2025) · International Journal of Environmental Sciences · doi:10.64252/g2mnqq21
Cyberski, C. (2025) · Refubium (Universitätsbibliothek der Freien Universität Berlin) · doi:10.17169/refubium-50215
Prevalence of Peripheral Neuropathy in Diabetic Patients
Gul, N., Tayong, F. M., Rios, V. L., Ullah, H., J, J. K., Ali, A., & Faisal, S. (2025) · Journal of BioMed Research and Reports · doi:10.59657/2837-4681.brs.25.169
Rukadikar, C. A., Geetha, M., Am, D., Renuka, K., Vinoth, R., Nishad, S., Rukadikar, A. R., & Singh, M. K. (2025) · Bioinformation · doi:10.6026/973206300214777
Quintal-Medina, I. A., López-Prieto, R. S., Romero-Torres, K. A., García-Ulloa, A. C., Gomez-Perez, F. J., & Almeda‐Valdés, P. (2026) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2025.501758
Xu, W., Li, L., Cai, J., Liu, Y., Han, C., Ye, X., Yi, J., & Zhang, M. (2026) · BMC Endocrine Disorders · doi:10.1186/s12902-026-02180-7
“DPN was diagnosed based on clinical symptoms, neurological examination, and electromyography (EMG) findings [21]. following established criteria.”
Li, Y. Q., Zhiguo, W., Ma, Y., & Yang, N. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1709785
“…required two or more manifestations from sensory symptoms, diminished re fl exes, or positive neurological signs consistent with distal symmetric polyneuropathy and (ii) electrodiagnostic con fi rmation necessitated abnormalities (amplitude/latency/NCV/F-wave) in two or more peripheral nerves (24).”
GÖÇER, A. B. (2019) · AYBU AVESIS
Ražanskaitė-Virbickienė, D. (2019) · Lithuanian University of Health Sciences
PARIKH, E., Almulla, A. K., Lovblom, L. E., BUDHRAM, D. R., Orszag, A., Falappa, M., Gad, H., Bril, V., & Perkins, B. A. (2026) · Journal of the Peripheral Nervous System · doi:10.1111/jns.70114
Rajaobelina, K. (2016) · theses.fr (ABES) · doi:10.70675/21440568zd16bz44e5z8448z76f7226a1092
“Après 10 ans de suivi dans l’étude EDIC, le risque de progression de la rétinopathie était réduit de 53% chez ces mêmes sujets (76) ; après 12 ans de suivi, le traitement intensif initial diminuait le risque d’évènements cardiovasculaires de 42% (77) ; et après 13 ans de suivi le risque de neuropathie était diminué de…”
BackgroundNerve Under Siege: Managing Diabetic Neuropathy and Pain
Alom, S., Ali, F., Abubakar, M., Yogi, S., & Bhat, H. R. (2026) · Springer eBooks · doi:10.1007/978-981-95-8946-3_3
Karadağ, M., TUTU, Ö. G., Bilen, V., & Özer, C. (2026) · BMC Family Practice · doi:10.1186/s12875-026-03356-9
“…glycaemic control and lower educational attainment emerged as the only independent correlates that increased the frequency of probable neuropathic pain, whereas associations with age, diabetes duration, hypertension and other comorbidities attenuated after adjustment [2, 10, 11, 23–29, 32– 35].”
Schmerzhafte diabetische Neuropathie: Diagnostik und Therapie
Mitrović, N. (2026) · Schmerz Nachrichten · doi:10.1007/s44180-026-00296-9
Diabetic retinal disease: A sensory neuropathy
Gardner, T. W., & Malik, R. A. (2026) · Handbook of clinical neurology · doi:10.1016/b978-0-443-22212-2.00001-x
Molefe, T. J., & Khumalo, N. (2020) · International Journal of Endocrinology Research · doi:10.33545/26646579.2020.v2.i1a.60
Quintal-Medina, I. A., López-Prieto, R. S., Romero-Torres, K. A., García-Ulloa, A. C., Gomez-Perez, F. J., & Almeda‐Valdés, P. (2026) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2026.501758
Choe, H. J., Koo, B. K., Hong, Y., Kim, N. H., Moon, J. S., Lee, Y., Cho, H., Kwak, S. H., Lim, S. K., Kim, D.-L., et al. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113388
Zhang, X., He, F., Pan, Y., & Ying, Q. (2026) · European journal of medical research · doi:10.1186/s40001-026-04833-8
“Needle electromyography was implemented when clinically indicated [15–17].”
Dago, P. K., Gouh, F. L., Gnahoré, P. H., Attiégoua, E., Anselme, N. Y., Bouadi, I., Hué, A., Kouassi, F., Yao, A., Danho, J., et al. (2026) · Open Journal of Endocrine and Metabolic Diseases · doi:10.4236/ojemd.2026.167015
Mechanisms, translational opportunities for diabetic polyneuropathy
Ong, H., Hong, M., & Zochodne, D. W. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1899469
“The DCCT/EDIC group suggested that at least 20% of T1DM patients developed DPN after 20 years (31).”
Choudhury, M., Morgan, P., Lau, D., Duckers, J., Ketchell, I., Speight, L., & Wong, F. S. (2026) · Journal of Diabetes and Clinical Research · doi:10.33696/diabetes.8.079
Electroneurographic profiles of peripheral neuropathy in diabetic patients in Lubumbashi
Mande, J.-P. N., Mbuyamba, E. B., Obadia, P. M., Nkulu, D. N., Lubaba, C. B., Mukalay, A., Lelubre, C., Ris, L., & E‐Andjafono, D. O. L. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1928343
Mukushev, A., & Rutkove, S. B. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-23516-0.00140-9
Eljali, N. H., Dugani, A., & AlMiladi, S. A. (2026) · Tripolitana Medical Journal
Pheripheral Neuropathy in Diabetis
Jadhav, D. D. L. D. S. (2024) · International Journal of Multidisciplinary Innovation and Research Methodology
Современные подходы к диагностике и лечению диабетической полинейропатии
Баринов, А. Н., Телышева, Ю. Б., Эмих, Е. В., & Мошхоева, Л. С. (2023) · Effective Pharmacotherapy
Zhu, Z., Zou, Q., Su, C., You, X., Zeng, W., Li, N., Thitinun, B., Li, Y., Junpeng, Y., & Zhang, W. (2026) · Journal of Diabetes Research · doi:10.1155/jdr/6233881
“However, due to the mixed nature of metabolic disorders and the complexity of peripheral nerve structures, researchers have gradually discovered that hyper-glycemia does not necessarily maintain a causal relationship with DPN [50–52].”
Hauser, W., Keller, J. E., Pasnoor, M., & Wright, D. E. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1854989
BindingDB Entry 50010930: Anti-diabetic drugs recent approaches and advancements.
BindingDB (2021) · UC San Diego · doi:10.7270/q2t43xn8
Mohr, J. A., Jiravský, O., Rucki, L., Godula, B. J., Samiec, J., Pekařová, A., Jakubovicova, E., Chovančík, J., Novàkovâ, M., & Pekár, M. (2026) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s604281
Frontiers in Diagnostic and Therapeutic approaches in Diabetic Sensorimotor Neuropathy, volume II
(2026) · Frontiers research topics · doi:10.3389/978-2-8325-8970-0
Lehrke, M., Stahl, A., Schürfeld, R., Ebert, T., Stirban, O. A., & Lobmann, R. (2026) · Elsevier eBooks · doi:10.1016/b978-3-437-23857-4.00035-7
Li, X., Hao, W., Lin, S., & Yang, N. (2024) · doi:10.3389/fendo.2024.1361707.s001
Sun, X., Yang, X., Zhu, X., Ma, Y., Li, X., Zhang, Y., Liu, Q., Fan, C., Zhang, M., Xu, B., et al. (2024) · doi:10.3389/fendo.2024.1354511.s001
Al-Saoudi, E., Christensen, M. M. B., Nawroth, P., Fleming, T., Hommel, E. E., Jørgensen, M. E., Fleischer, J., & Hansen, C. S. (2022) · doi:10.3389/fendo.2022.891442.s002
Synkope aus der Sicht des Neurologen
Bickel, A., & Röther, J. (2014) · Herz · doi:10.1007/s00059-014-4095-0
Metadata
- Authors
- Martin, C. L., Albers, J. W., Pop-Busui, R., & for the DCCT/EDIC Research Group
- Affiliations
- University of Michigan (US)
- Department of Internal Medicine, Division of Metabolism, Endocrinology and Diabetes, University of Michigan Medical School, Ann Arbor, MI
- Corresponding author
- Martin, Catherine L.
- ORCID
- Martin, Catherine L.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2013-12-11
- Volume
- 37
- Issue
- 1
- Pages
- 31-38
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3868000
- OpenAlex
- W2115038969
- Cited by
- 499
- References
- 30
- Citations by year
- 2026: 25 · 2025: 27 · 2024: 45 · 2023: 38 · 2022: 40 · 2021: 57 · 2020: 50 · 2019: 41 · 2018: 45 · 2017: 28 · 2016: 34 · 2015: 42 · 2014: 23 · 2013: 4
- FWCI
- 27.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Eli Lilly and Company
- Sanofi
- BD
- Roche Diabetes Care
- National Institutes of Health (UL1TR000041, UL1TR000114, 5u01dk094157-13, UL1TR001449)
- Abbott Diabetes Care
- National Eye Institute
- National Institute of Diabetes and Digestive and Kidney Diseases (U01DK094176, U01-DK094157, P30DK020572)
- National Institute of Neurological Disorders and Stroke
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- diabetic peripheral neuropathy, cardiac autonomic neuropathy, type 1 diabetes, tight glycemic control, neuropathy progression, neuropathic pain, hypoglycemia awareness, genitourinary function, Michigan Neuropathy Screening Instrument, DCCT/EDIC, neuropathy prevention
- MeSH terms
- Adolescent, Adult, Aged, Blood Glucose, Blood Pressure, Diabetes Mellitus, Type 1, Diabetic Neuropathies, Dose-Response Relationship, Drug, Female, Glycated Hemoglobin, Humans, Insulin, Male, Middle Aged, Neural Conduction, Peripheral Nervous System Diseases, Risk Factors, Incidence, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.